NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 4 filers reported holding NPS PHARMACEUTICALS INC in Q4 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
| Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
| OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
| SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
| First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
| FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
| BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
| Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |